Newsfeeds - Spark Newswire

2 minute read

Earnings

Bolt Biotherapeutics’s Return On Capital Employed Overview

Today, 7:44 PM

Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16 million.

BOLT

2 minute read

Bolt Biotherapeutics To Present Updates For Three Preclinical Immuno-Oncology Pipeline Programs At AACR Annual Meeting 2022 Apr. 12 And 13

By Bill Haddad

Today, 7:44 PM

Bolt Biotherapeutics (NASDAQ:BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology therapeutics that combine the targeting precision of antibodies with the power of both the innate and

BOLT

2 minute read

Bolt Biotherapeutics To Present Updates For 3 Preclinical Immuno-Oncology Pipeline Programs At American Association Of Cancer Research Meeting Apr. 8-13

By Benzinga Newsdesk

Today, 7:44 PM

BOLT

19 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 7:44 PM

On Friday, 313 companies hit new 52-week lows.

AAON

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 7:44 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

Morgan Stanley Downgrades Bolt Biotherapeutics to Equal-Weight, Lowers Price Target to $11

By Benzinga Newsdesk

Today, 7:44 PM

Morgan Stanley analyst Matthew Harrison downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Overweight to Equal-Weight and lowers the price target from $45 to $11.

BOLT

3 minute read

Mid-Afternoon Market Update: Dow Jumps 700 Points; Del Taco Restaurants Shares Spike Higher

By Lisa Levin

Today, 7:44 PM

Toward the end of trading Monday, the Dow traded up 2.11% to 35,308.84 while the NASDAQ rose 1.24% to 15,272.25. The S&P also rose, gaining 1.51% to 4,607.08.

ACET

3 minute read

36 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 7:44 PM

Gainers

ACET

3 minute read

Mid-Morning Market Update: Markets Mostly Higher; Science Applications International Posts Upbeat Earnings

By Lisa Levin

Today, 7:44 PM

Following the market opening Monday, the Dow traded up 1.35% to 35,048.01 while the NASDAQ fell 0.17% to 15,059.43. The S&P also rose, gaining 0.59% to 4,565.21.

ACET

3 minute read

Events
News

Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating A Safe And Well-tolerated Profile And Emerging Clinical Activity At The ESMO Immuno-Oncology Congress 2021

By Benzinga Newsdesk

Today, 7:44 PM

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and

BOLT